New hope for kids with severe facial growths: drug trial aims to shrink tumors
NCT ID NCT03243019
Summary
This study is testing if a drug called rapamycin can shrink severe lymphatic growths in the face and neck of children. It involves 28 young patients taking the oral medication for six months. Doctors will use MRI scans to see if the growths shrink by at least 20% and will also check if it reduces symptoms and improves the child's quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hu Robert Debre Aphp - Paris
RECRUITINGParis, France
-
Hôpital Jeanne de Flandres, CHU
RECRUITINGLille, France
Contact
Conditions
Explore the condition pages connected to this study.